Fibromyoma or carcinoma corporis uteri
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 7, 2002
Issued Date -
N/A
app pub date -
Feb 5, 1999
filing date -
Aug 7, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
In a process for rapidly and inexpensively diagnosing malignant diseases or their precursor stages, samples of arterial and/or capillary blood and of venous blood are withdrawn from a patient and the percentage shares of three groups of blood cells in the blood samples are determined wherein a first group includes blood cells of a size .ltoreq.8 .mu.m, a second group includes blood cells of a 9 .mu.m and 10 .mu.m and the third group includes blood cells of a size .gtoreq.11 .mu.m. The percentage shares are multiplied by weighting factors .alpha..sub.1 and .beta..sub.1, and the values y=.SIGMA..alpha..sub.i [(N.sub.i).sup.A ]-.SIGMA..alpha..sub.i [(N.sub.i).sup.V ] and x=.SIGMA..beta..sub.i [(N.sub.i).sup.A ]-.SIGMA..beta..sub.i [(N.sub.i).sup.V ], are calculated and from the locations of x and y in an x/y coordinate system, the presence of Ca. corp. uteri or its precursor stages is determined.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully